WHO ICTRP trial
A Randomised Double-Blind, Double-Dummy, Placebo-Controlled, Stratified…
EUCTR2010-019095-70-RO · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019095-70-RO |
|---|---|
| Public title | A Randomised Double-Blind, Double-Dummy, Placebo-Controlled, Stratified, Parallel-Group, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of GSK2190915 Tablets Administered Once Daily, Fluticasone Propionate Inhalation Powder 100mcg Twice Daily and Montelukast 10mg Daily compared with Placebo for 8 Weeks in Adolescent and Adult Subjects with Persistent Asthma while Treated with Short Acting Beta2-agonist |
| Scientific title | A Randomised Double-Blind, Double-Dummy, Placebo-Controlled, Stratified, Parallel-Group, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of GSK2190915 Tablets Administered Once Daily, Fluticasone Propionate Inhalation Powder 100mcg Twice Daily and Montelukast 10mg Daily compared… |
| Primary sponsor | GlaxoSmithKline Research and Development Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Romania;Bulgaria |
| Conditions | Asthma MedDRA version: 12.1 Level: LLT Classification code 10003553 Term: Asthma |
| Interventions | Product Name: GSK2190915 Product Code: GSK2190915 Pharmaceutical Form: Tablet Concentration unit: µg microgram(s) Concentration type: range Concentration number: 10-200 Pharmaceutical form of the placebo: Tablet Route of administration of… |
| Registration date | May 13, 2010 |
| Target size | 630 |
| Secondary IDs | LPA112186 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: